During cataract surgery, the clouded natural lens of the eye is replaced with a new plastic lens called an intraocular lens implant. Typically, this procedure can be performed under eye drop anesthesia in just a matter of minutes as an outpatient at an ambulatory surgery center. The new lens implant is available in various shapes and sizes. Some are used for those with underlying nearsightedness (myopia), farsightedness (hyperopia), and astigmatism as well as for

(Read More)

On November 18, 2011, the F.D.A. approved a new medication for the treatment of neovascular age-related macular degeneration (wet AMD). This new medication, afilbercept (Eylea™), produced by Regeneron is a new weapon in the armamentarium against the blindness caused by wet AMD. Wet macular degeneration results from new blood vessels growing into the subretinal space at the direction of an antigen called vascular endothelial growth factor, or VEGF.

(Read More)

Congratulations, Dr. Newsom! We are proud of you!

You can view this article by clicking on the attachment.

(Read More)

Attachments

(JPG FILE)

(JPG FILE)